Biomedical International R+D GmbH

Biomedical International is an internationally active company that possesses specific expertise and years of know-how in the fields of immunology and allergology.

Biomed's products SMAiCOM® and immunoBON® are based on IP from its in-house research & development activities in the medical sector. Biomed scientists enjoy an international reputation and have specific expertise in immunology and allergology, from the development of lead compounds and proof-of-concept studies to clinical trials.

At WHX 2026 Biomed proudly presents SMAiCOM®, a laboratory device for non-invasive automated image analysis in studies involving small laboratory animals.